... initiation of therapy. The aim of our study was to assess the reliability of a routinely performed screening examination. Patients and Methods: Newborns were examined by a pediatrician between 48 and 72 h after birth. Boys with suspected cryptorchidism were double-checked by a pediatric urologist within 24 h...

...Matthew B. Clements; Basil Abdalla; Stephen H. Culp; Raymond A. Costabile; Tracey L. Krupski Background: In May 2012, the US Preventive Services Task Force assigned prostate-specific antigen-based screening a grade D recommendation, advising against screening at any age. Our objective...

... aggressiveness and selection of patients eligible for conservative management. Two factors limiting the clinical implementation of validated biomarker candidates are costs and local availability. For these reasons, currently, their true clinical role starts after routine screening with prostate-specific antigen...

.... Urokinase Prostate cancer Screening Original Paper Urol Int 1994;52:159-161 Kurt Lehmanna Eugen Pias3 Kurt Gautschib Dieter Hauri3 Urologie Clinic and Department of Clinical Chemistry, University Hospital Zürich, Switzerland Prognostic Value of Urokinase Plasminogen Activator for Prostatic Carcinoma...

... and high monetary and human costs of the test and by the lack of proof that treatment is effective for those tumors detected. One must conclude that universal screening is not now warranted and will await demonstration of effectiveness by controlled studies. 2 2 2010 © 1991 S. Karger AG, Basel...